Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Jo Pai Chen"'
Autor:
Muh-Hwa Yang, Tien-Hua Chen, Hung-Ming Wang, Jason Chia-Hsun Hsieh, Huai-Cheng Huang, Meng-Che Hsieh, Chia-Jui Yen, Shang-Yin Wu, Chun-Hung Hua, Ming-Yu Lien, Yi-Fang Chang, Hui-Ching Wang, Chih-Yen Chien, Tai-Lin Huang, Hsueh-Ju Lu, Jin-Ching Lin, Chen-Chi Wang, Yi-Chun Liu, Jo-Pai Chen, Wei-Chen Lu, Ching-Yi Yiu, Chien-Liang Lin, Pei-Jen Lou, Pen-Yuan Chu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background In recent years, the addition of cetuximab to chemotherapy has improved treatment outcomes for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). In this study, we present the real-world survival
Externí odkaz:
https://doaj.org/article/c0bb5c565c1549cc89406fca96fbad68
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 2, Pp 273-282 (2024)
Background/purpose: Patients with advanced cancer sometimes travel to locations that have the treatment that they need. We explored the prognostic factors of survival in patients with advanced lung cancer who travel long distances in Taiwan. Methods:
Externí odkaz:
https://doaj.org/article/5694c46341104edab755971744d134e2
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ce7f1df5e0ab4b609e40c0940983d4ec
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/166799d03cd3407c9e6429b3056d5bc1
Publikováno v:
Journal of Cancer Research and Practice, Vol 4, Iss 1, Pp 31-34 (2017)
Metronomic chemotherapy has shown encouraging efficacy and low toxicity in various tumor types and is one of the best treatment options for heavily pretreated patients or patients with advanced age and/or poor performance status. We demonstrated a pa
Externí odkaz:
https://doaj.org/article/d0211440c8af44a79196d7bec6d00a31
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Chun-Wei Wang, Jenny Ling-Yu Chen, Chia‐Chun Wang, Sung-Hsin Kuo, Chien‐Hsieh Chiang, Jo-Pai Chen, Yu-Li Lin, Chia-Wei Shen, Yu-Sen Huang
Publikováno v:
Head & Neck. 41:3201-3210
BACKGROUND We hypothesized that patients with head and neck squamous cell carcinoma (HNSCC) with smoking cessation during curative chemoradiotherapy (CRT) had fewer complications and lower tumor progression risks. METHODS Sixty-three patients with no
Autor:
Muh-Hwa Yang, Chen Tien Hua, Meng-Che Hsieh, Huai-Cheng Huang, Chih-Yen Chien, Tai-Lin Huang, Chun-Hung Hua, Ming-Yu Lien, Hui-Ching Wang, Hsueh-Ju Lu, Chia-Jui Yen, Shang-Yin Wu, Jo-Pai Chen, Wei-Chen Lu, Jin-Ching Lin, Chen-Chi Wang, Yi-Chun Liu, Hung-Ming Wang, Jason, Chia-Hsun Heieh, Pei-Jen Lou
Publikováno v:
Journal of Clinical Oncology. 40:e18013-e18013
e18013 Background: Cetuximab significantly improved survival outcomes of recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) when combined with chemotherapy. The aim of this study was to explore clinical outcomes, prognostic fac
Autor:
Jo-Pai Chen, Wei-Chen Lu, Hsu Wu, Tsui-Mai Kao, Keng-Man Chiang, Hsing-wu Chen, Sung-Hsin Kuo
Publikováno v:
Journal of Clinical Oncology. 40:328-328
328 Background: ESCC is a health burden in Taiwan due to smoking and drinking habits. In R/M setting, the prognosis is worse. In 2021, KN590 study(pembrolizumab with chemotherapy in CPS≥10%), CM648 study(nivolumab with chemotherapy or nivolumab wit